Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Efficacy and Safety of CartiPRO Injection to Alleviate Knee Pain in Patients With Osteoarthritis and/or Diverse Cartilage Defects: a Multicenter, Single-blind, Randomized, Non-inferiority, Sponsor Initiated Trial

NCT07267793 is registered in ClinicalTrials.gov with DALIM TISSEN Co., Ltd. as lead sponsor.

NCT NCT07267793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07267793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Efficacy and Safety of CartiPRO Injection to Alleviate Knee Pain in Patients With Osteoarthritis and/or Diverse Cartilage Defects: a Multicenter, Single-blind, Randomized, Non-inferiority, Sponsor Initiated Trial
Lead sponsor
DALIM TISSEN Co., Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 3, 2025
Completion date
June 30, 2027
Enrollment
194 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cartilage defects of the knee, degenerative joint disease of knee, knee osteoarthritis, knee pain arthritis, osteoarthritis